Results 231 to 240 of about 5,128,022 (309)

Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories. [PDF]

Nat Commun
Zwerwer LR, Peto TEA, Pouwels KB, Walker AS, COVID-19 Infection Survey team.   +4 more
europepmc   +1 more source

Case Report: Therapeutic effect of efgartigimod in refractory anti-GQ1b antibody syndrome coexisting with myasthenia gravis. [PDF]

Front Immunol
Watanabe K, Takahashi S, Kanda A, Watanabe T, Kakinuma Y, Yano S, Kinno R.   +6 more
europepmc   +1 more source

8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines. [PDF]

J Cell Mol Med
Marquez J, Dong J, Yue B, Hayashi J, Dong C, Oshimura M, Serrero G.   +6 more
europepmc   +1 more source

High-throughput strategies for monoclonal antibody screening: advances and challenges. [PDF]

J Biol Eng
Wang XD, Ma BY, Lai SY, Cai XJ, Cong YG, Xu JF, Zhang PF.   +6 more
europepmc   +1 more source

Case Report: Anti-ADAM23 antibody: an overlooked autoantibody against VGKC-complex in autoimmune encephalitis. [PDF]

Front Immunol
Ni P, Bai L, Jiang N, Fan S, Yao M, Ren H, Guan H.   +6 more
europepmc   +1 more source

Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors.

Nanoscale Horiz
Zelenetz SR, Park H, Qiang W, Lin G, Almunif S, Sharma SH, Scariot DB, Lu J, Reichert RW, Zhang B, Scott EA.   +10 more
europepmc   +1 more source

Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform. [PDF]

Drug Deliv
Nyesiga B, Hägerbrand K, Varas L, Gjörloff Wingren A, Ohlin M, Ellmark P, von Schantz L.   +6 more
europepmc   +1 more source

Comprehensive analysis of SARS-CoV-2 Spike evolution: epitope classification and immune escape prediction. [PDF]

Virus Evol
Teruel NFB, Crown M, Rajsbaum R, Bashton M, Najmanovich R.   +4 more
europepmc   +1 more source

Diagnostic value of BNLF2b antibody, dual-antibody testing and Epstein-Barr virus DNA in nasopharyngeal carcinoma: a prospective cohort study in Hunan Province, China. [PDF]

BMJ Open
Qu B, Sun L, Deng H, Liu Q, Shen H, Xiao P.   +5 more
europepmc   +1 more source